

Cover Story
Free
By Matthew Bin Han Ong
The power morcellator should no longer be used for hysterectomies or fibroid removal in the vast majority of women getting these procedures, FDA declared in a highly anticipated guidance document Nov. 24.
In Brief


Drugs & Targets
Trending Stories
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- House passes Mikaela Naylon Give Kids a Chance Act—next step, the Senate
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program











